Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP650666.RADjI3wcqsUAXVbDmGjaqcuHt55M5ArzNknG5b0uYbmwA130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650666.RADjI3wcqsUAXVbDmGjaqcuHt55M5ArzNknG5b0uYbmwA130_provenance.
• NP855912.RAj981YUuDPwAuY2XYw8yGDezZ6Ig8MRWebZn02Rd9m9Y130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855912.RAj981YUuDPwAuY2XYw8yGDezZ6Ig8MRWebZn02Rd9m9Y130_provenance.
• NP441361.RAZPAU5322-MhgmXEsRXM3cHEaRNvzqBLvdoU0udBb63Y130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP441361.RAZPAU5322-MhgmXEsRXM3cHEaRNvzqBLvdoU0udBb63Y130_provenance.
• NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_provenance.
• NP591500.RATJ-d_RN4ofNfCG60-xDA5qIOud5wOKcjk_YFr1VdY-o130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591500.RATJ-d_RN4ofNfCG60-xDA5qIOud5wOKcjk_YFr1VdY-o130_provenance.
• NP756986.RAdSfNN71F_038yK7BxIhxWxIc1O9rgWDWaBk45CR0PHI130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756986.RAdSfNN71F_038yK7BxIhxWxIc1O9rgWDWaBk45CR0PHI130_provenance.
• assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP773265.RAjyRW67sb4V7lnsSIiiCptWVU6o-A4Il0Jkf95gUNI40130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773265.RAjyRW67sb4V7lnsSIiiCptWVU6o-A4Il0Jkf95gUNI40130_provenance.
• NP773266.RAkcBTgMbcGPPiCY7lgaydwQuzmr7cQxnauPmZ6Rb2CIE130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773266.RAkcBTgMbcGPPiCY7lgaydwQuzmr7cQxnauPmZ6Rb2CIE130_provenance.
• NP841111.RAGLhLtA2IgVQhPjgpHIeIMYo3hlW9CL8neL_2-Z6dcpc130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841111.RAGLhLtA2IgVQhPjgpHIeIMYo3hlW9CL8neL_2-Z6dcpc130_provenance.
• NP773269.RAMzspdGXKHF6B2Z6uSNZ4SCb_aiqzcwPxgUfZ65zMyTg130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773269.RAMzspdGXKHF6B2Z6uSNZ4SCb_aiqzcwPxgUfZ65zMyTg130_provenance.
• NP756445.RA43Nh8lDD3t_kNEb_5ieMQBiD0DIUsqxVllJPWcOKHMI130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756445.RA43Nh8lDD3t_kNEb_5ieMQBiD0DIUsqxVllJPWcOKHMI130_provenance.
• NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_provenance.